# Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients

> **NCT04346446** · PHASE2 · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 29 (actual)

## Conditions studied

- COVID

## Interventions

- **DRUG:** Convalescent Plasma Transfusion
- **OTHER:** Supportive Care
- **DRUG:** Random Donor Plasma

## Key facts

- **NCT ID:** NCT04346446
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-20
- **Primary completion:** 2020-05-30
- **Final completion:** 2020-05-30
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2020-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04346446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04346446, "Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04346446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*